Assessing treatment efficacy in noninferiority trials-Reference-Cited by-同舟云学术

Assessing treatment efficacy in noninferiority trials

Published:2003-04 Issue:2 Volume:24 Page:147-155
ISSN:0197-2456
Container-title:Controlled Clinical Trials
language:en
Short-container-title:Controlled Clinical Trials

Author:

Wang Sue-Jane,Hung H.M.James

Publisher

Elsevier BV

Subject

Pharmacology

Reference12 articles.

1. Some fundamental issues with noninferiority testing in active-controlled trials;Hung;Stat Med,2003

2. Treatment evaluation in active control studies;Fleming;Cancer Treat Rep,1987

3. Showing a treatment is good because it is not bad;Blackwelder;Control Clin Trials,2002

4. Temple R. Difficulties in evaluating positive control trials. Proceedings of the Biopharmaceutical Section of American Statistical Association 1983; p. 1–7.

5. “Proving the null hypothesis” in clinical trials;Blackwelder;Control Clin Trials,1982

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A reproducibility probability-based bias-adjustment approach on the specification of non-inferiority margin using historical data;Journal of Biopharmaceutical Statistics;2019-06-19

2. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study;The Lancet Oncology;2018-03

3. Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus inDe NovoRenal Transplant Recipients: 12-Month Data;American Journal of Transplantation;2017-01-04

4. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials;Statistical Methods in Medical Research;2016-09-01

5. Avoiding ambiguity with the Type I error rate in noninferiority trials;Journal of Biopharmaceutical Statistics;2015-08-07